Works matching IS 09024441 AND DT 2010 AND VI 85 AND IP 2
Results: 14
BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 99, doi. 10.1111/j.1600-0609.2010.01450.x
- By:
- Publication type:
- Article
Triose phosphate isomerase deficiency associated with two novel mutations in TPI gene.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 170, doi. 10.1111/j.1600-0609.2010.01451.x
- By:
- Publication type:
- Article
Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 164, doi. 10.1111/j.1600-0609.2010.01452.x
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma with Dutcher bodies.
- Published in:
- 2010
- By:
- Publication type:
- Other
Aberrant methylation of GTPase regulator associated with the focal adhesion kinase ( GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The clinical and biological features of a series of immunophenotypic variant of B-CLL.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 120, doi. 10.1111/j.1600-0609.2010.01454.x
- By:
- Publication type:
- Article
The G-Allele of the PSMA6−8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 108, doi. 10.1111/j.1600-0609.2010.01455.x
- By:
- Publication type:
- Article
The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 93, doi. 10.1111/j.1600-0609.2010.01492.x
- By:
- Publication type:
- Article
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 130, doi. 10.1111/j.1600-0609.2010.01456.x
- By:
- Publication type:
- Article
A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 139, doi. 10.1111/j.1600-0609.2010.01459.x
- By:
- Publication type:
- Article
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 114, doi. 10.1111/j.1600-0609.2010.01466.x
- By:
- Publication type:
- Article
Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 149, doi. 10.1111/j.1600-0609.2010.01467.x
- By:
- Publication type:
- Article
Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 158, doi. 10.1111/j.1600-0609.2010.01468.x
- By:
- Publication type:
- Article